News
5 students get selections in Stemcyte India. Congratulations!!!
20 Aug 2022
We are happy to share with you that we have conducted an On Campus placement drive of StemCyte India Therapeutics Pvt. Ltd. for Pharmacy, Biotech & Management students of the 2022 batch on 20th June 2022 and got 05 Selections in it. Details are as follows:
About Company : StemCyte India Therapeutics Pvt. Ltd.
StemCyte India Therapeutics Pvt. Ltd. (StemCyte India) was born at the 1 st Vibrant Gujarat Summit held in 2007, spearheaded by Honorable Prime Minister Shri Narendra Modi.
- StemCyte India is a joint venture between StemCyte Inc. (USA), Apollo Hospital Enterprises Ltd., and Cadila Pharmaceuticals Ltd. StemCyte India’s headquarters and processing facility are strategically located in Gujarat state (The hub of Thalassemia and Sickle Cell Anemia).
- It was established in 2008, dedicated to the collection, processing, testing, and storage of both – private and public umbilical cord blood units and its therapeutic applications.
- Globally, StemCyte Inc., USA; StemCyte Taiwan, and StemCyte India work on a “Hybrid+” model. Each establishment has a core competency in Public Cord Blood Banking, Private Cord Blood Banking, and Therapeutic Applications and is also actively involved in Clinical Trials.
- As a group, StemCyte has facilitated 2200 cord blood transplants at 315 transplant centers across all continents.StemCyte India was established in 2008 and started its commercial operations in 2010.
- The success of stem cell technology is not just in banking but in its therapeutic application……. And only StemCyte has it all. Provide a complete solution – from Banking to Therapeutic Application – all under one roof.
- StemCyte’s motto “It is not just about saving blood….It’s about saving lives”
Profiles Offered: Customer Delight Executive
Total Selections : 05
1. 181201002 - ABHAY PRATAP - B.Pharm
2. 1801506011 – KM LAVLI DEVI - B.Tech-Biotech
3. 1801506026 - SHREESH KUMAR DUBEY - B.Tech-Biotech
4. 2002616002 - AFREEN BEGUM - MBA
5. 2002603010 - DEEPANSH PORWAL - MBA
Eligible Branches : Pharmacy, Biotech & Management students of the 2022 batch
